How does kava work?

    Last Updated: March 13, 2024

    The kavalactones contained in kava root are a group of bioactive compounds responsible for its effects. The most notable kavalactones include kavain, dihydrokavain, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin.[1][2][3] In animal studies, kavalactones have demonstrated the ability to cross the blood-brain barrier, which helps explain why kava has a psycho-emotional effect.[4] When taken orally at a dosage of 120 mg of kava per kg of body weight, effects have been seen within an hour as kavalactones begin to accumulate in the brain.[5][6]

    Kavalactones may impart their psycho-emotional effects via glutaminergic, GABAergic, dopaminergic, and/or serotonergic signaling. It has so far proved difficult to establish the effects of individual kavalactones for two reasons: first, the effects of any individual kavalactone may be dose-dependent in ways we don’t understand; and second, when kavalactones are combined, they may not only have interactions, but those interactions could potentially vary depending on the ratio of the kavalactones in combination. In addition, both of these factors may affect humans and animal models differently, making it even harder to tease out these complex relationships. For example, case studies have reported seeing clinical signs of dopamine receptor blockage as a result of kava consumption,[7] but animal studies have not always supported the existence of an antidopaminergic effect.[8][9][10] Similarly, while a rodent trial found that mixed kavalactones did not affect serotonin levels, isolated dihydromethysticin increased serotonin in rats, while isolated desmethoxyyagonin produced reductions in it.[8]

    While kavain damaged cultured rat neurons in vitro at concentrations of 300 µM or greater (i.e., greater than or equal to 300 micromoles of kavain per liter),[11] the kavalactones dihydromethysticin and methysticin may hold neuroprotective effects.[12] Animal and nonclinical studies suggest that dihydromethysticin and methysticin may also impart sedative effects through indirect GABAergic signaling.[8][4][13][14][15]

    As with any plant or herbal preparation, factors such as plant part, growth conditions, and extraction methods may affect kavalactone content. Kava preparations with a standardized kavalactone concentration are more likely to produce consistent effects.

    References

    1. ^Kava Kava. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury; USA: National Institute of Diabetes and Digestive and Kidney Diseases, updated April 2018, cited January 2024(2012)
    2. ^Weiss J, Sauer A, Frank A, Unger MExtracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro.Drug Metab Dispos.(2005-Nov)
    3. ^X G He, L Z Lin, L Z LianElectrospray high performance liquid chromatography-mass spectrometry in phytochemical analysis of kava (Piper methysticum) extractPlanta Med.(1997 Feb)
    4. ^Kennon M Garrett, Garo Basmadjian, Ikhlas A Khan, Brian T Schaneberg, Thomas W SealeExtracts of kava (Piper methysticum) induce acute anxiolytic-like behavioral changes in micePsychopharmacology (Berl).(2003 Oct)
    5. ^Keledjian J, Duffield PH, Jamieson DD, Lidgard RO, Duffield AMUptake into mouse brain of four compounds present in the psychoactive beverage kava.J Pharm Sci.(1988-Dec)
    6. ^Thompson R, Ruch W, Hasenöhrl RUEnhanced cognitive performance and cheerful mood by standardized extracts of Piper methysticum (Kava-kava)Hum Psychopharmacol.(2004 Jun)
    7. ^Schelosky L, Raffauf C, Jendroska K, Poewe WKava and dopamine antagonism.J Neurol Neurosurg Psychiatry.(1995-May)
    8. ^Baum SS, Hill R, Rommelspacher HEffect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats.Prog Neuropsychopharmacol Biol Psychiatry.(1998-Oct)
    9. ^Serdarevic N, Eckert GP, Müller WEThe effects of extracts from St. John's Wort and Kava Kava on brain neurotransmitter levels in the mouse.Pharmacopsychiatry.(2001-Jul)
    10. ^Dinh LD, Simmen U, Bueter KB, Bueter B, Lundstrom K, Schaffner WInteraction of various Piper methysticum cultivars with CNS receptors in vitro.Planta Med.(2001-Jun)
    11. ^Mulholland PJ, Prendergast MAPost-insult exposure to (+/-) kavain potentiates N-methyl-D-aspartate toxicity in the developing hippocampus.Brain Res.(2002-Jul-26)
    12. ^Backhauss C, Krieglstein JExtract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents.Eur J Pharmacol.(1992-May-14)
    13. ^Davies LP, Drew CA, Duffield P, Johnston GA, Jamieson DDKava pyrones and resin: studies on GABAA, GABAB and benzodiazepine binding sites in rodent brain.Pharmacol Toxicol.(1992-Aug)
    14. ^Jussofie A, Schmiz A, Hiemke CKavapyrone enriched extract from Piper methysticum as modulator of the GABA binding site in different regions of rat brain.Psychopharmacology (Berl).(1994-Dec)
    15. ^Cribb L, Sarris J, Savage KM, Byrne GJ, Metri NJ, Scholey A, Stough C, Bousman CAEffect of kava (Piper methysticum) on peripheral gene expression among individuals with generalized anxiety disorder: A post hoc analysis of a randomized controlled trial.Phytother Res.(2023-Dec)